List of SBIR/STTR awards granted to Acrigen Biosciences
Acrigen BiosciencesName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Acrigen Biosciences in April, 2020 for $252,131.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM137621-01 | Phase I | 252,131 | April 2, 2020 | |||||||
A STTR Phase I contract was awarded to Acrigen Biosciences in April, 2021 for $256,580.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41TR003752-01 | Phase I | 256,580 | April 19, 2021 | |||||||
A SBIR Phase I contract was awarded to Acrigen Biosciences in February, 2022 for $256,580.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM145002-01 | Phase I | 256,580 | February 15, 2022 | |||||||
A SBIR Phase II contract was awarded to Acrigen Biosciences in March, 2022 for $1,000,000.0 USD from the National Science Foundation. | SBIR | 2136335 | Phase II | 1,000,000 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Acrigen Biosciences in August, 2020 for $225,000.0 USD from the National Science Foundation. | SBIR | 2015148 | Phase I | 225,000 | August 15, 2020 |
